News | ESC | July 21, 2020

European Society of Cardiology Announces Late-Breaking Study Presentations at its 2020 Virtual Congress

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest clinical science presentations in cardiology at the 2020 annual congress digital meeting. The meeting has gone virtual due to the ongoing pandemic. 

The European Society of Cardiology (ESC) will host several Hot Lines sessions that will include some of the latest clinical science presentations in cardiology at the 2020 annual congress digital meeting. The meeting has gone virtual due to the ongoing pandemic. 

The congress is planned for Saturday, Aug. 29, through Tuesday Sept. 1, 2020. Read more on ECS's move to a digital meeting.

ESC said the event will include live presentations and panel discussions. To find out more, visit the event website at https://www.escardio.org/Congresses-&-Events/ESC-Congress

Hot Line sessions below are all in Central European Summer Time (CEST):

Saturday, Aug. 29
   • Hot Line 1: EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes. 14:30 - 15:00
   • Hot Line 2: EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy. 15:30 - 16:00
   • Hot Line 3: EAST – AFNET 4: Effects of Early Rhythm Control Therapy in Patients with Atrial Fibrillation. 17:00 - 17:30

 

Sunday, Aug. 30
   • Hot Line 4: ATPCI - Trimetazidine in Angina Patients with Recent Successful Percutaneous Coronary Intervention: a Randomized, Double-Blind, Placebo-Controlled Trial. 14:00 - 14:30
   • Hot Line 5: POPULAR TAVI -Aspirin With or Without Clopidogrel. 14:30 - 15:00
   • Hot Line 6: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF. 16:30 - 17:00

 

 

Monday, Aug. 31
   • Hot Line 7: LoDoCo2 Low-Dose Colchicine in Coronary Disease. 14:00 - 14:30
   • Hot Line 8: HOME-PE - Hospitalisation or Outpatient Management of PE Patients - HESTIA vs. Simplified PESI. 14:30 - 15:00
   • Hot Line 9: BPLTTC - Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure. 16:30 - 17:00

 

Tuesday, Sept. 1
   • Hot Line 10: BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19. 14:00 - 14:30
   • Hot Line 11: IMPACT-Afib Implementation of Stroke Prevention in Atrial Fibrillation. 14:30 - 15:00
   • Hot Line 12: REALITY - A Trial of Transfusion Strategies for Myocardial Infarction and Anemia. 16:30 - 17:00

 

Other ESC Clinical Studies

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study
 

Read the article Highlights From the 2019 ESC Congress.
 


Related Content

News | Cardiovascular Clinical Studies

April 20, 2023 — Researchers led by Northwestern University and the University of Texas at Austin (UT) have developed ...

Home April 20, 2023
Home
News | Cardiovascular Clinical Studies

April 5, 2023 — Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced the release of a new study ...

Home April 05, 2023
Home
News | Cardiovascular Clinical Studies

March 29, 2023 — Irregular sleep patterns may play a role in the pathophysiologic development of cardiovascular disease ...

Home March 29, 2023
Home
News | Cardiovascular Clinical Studies

March 27, 2023 — Tenax Therapeutics, Inc., a specialty pharmaceutical company focused on identifying, developing and ...

Home March 27, 2023
Home
News | Cardiovascular Clinical Studies

March 24, 2023 — Vaxxinity, Inc., a Cape Canaveral, FL-based company pioneering the development of a new class of ...

Home March 24, 2023
Home
News | Cardiovascular Clinical Studies

March 22, 2023 — Ancora Heart, Inc., a privately-held Santa Clara, CA-based company developing a completely ...

Home March 22, 2023
Home
News | Cardiovascular Clinical Studies

March 21, 2023 — The first platform to combine real-world cardiology data from millions of people in multiple European ...

Home March 21, 2023
Home
News | Cardiovascular Clinical Studies

March 13, 2023 — BioCardia, Inc., developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2023
Home
News | Cardiovascular Clinical Studies

March 8, 2023 — A unique community-based partnership, the African American Heart Study, will be conducted to measure the ...

Home March 08, 2023
Home
News | Cardiovascular Clinical Studies

March 6, 2023 — A multifaceted intervention to improve prescribing practices increased the likelihood that patients with ...

Home March 06, 2023
Home
Subscribe Now